Chondrosarcoma diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Chondrosarcoma}} {{CMG}}; {{AE}} == Overview == == Diagnostic Study of Choice == === Study of choice === [Name of the investigation] is the gold standard test fo...")
 
No edit summary
Line 81: Line 81:
* [2nd investigation]
* [2nd investigation]


=== Name of Diagnostic Criteria ===
===Enneking (MSTS) Staging System===
*The Enneking surgical staging system (also known as the MSTS system) for malignant [[Musculoskeletal system|musculoskeletal]] [[Tumor|tumors]] based on histological and [[radiographic]] characteristics of the tumor host margin.<ref name="pmid20333492">{{cite journal| author=Jawad MU, Scully SP| title=In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system. | journal=Clin Orthop Relat Res | year= 2010 | volume= 468 | issue= 7 | pages= 2000-2 | pmid=20333492 | doi=10.1007/s11999-010-1315-7 | pmc=2882012 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20333492  }} </ref><ref>{{cite book | last = Peabody | first = Terrance | title = Orthopaedic oncology : primary and metastatic tumors of the skeletal system | publisher = Springer | location = Cham | year = 2014 | isbn = 9783319073224 }}</ref>
*It is widely accepted and routinely used staging system.


'''It is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.'''
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center"
 
| valign="top" |
[Disease name] is primarily diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].
|-
 
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Stages}}
OR
! style="background: #4479BA; width: 300px;" |{{fontcolor|#FFF|Grade}}
 
! style="background: #4479BA; width: 300px;" |{{fontcolor|#FFF|Site}}
There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].
! style="background: #4479BA; width: 300px;" |{{fontcolor|#FFF|Metastasis}}
 
|-
OR
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |IA
 
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | G1: Low grade
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | T1: Intracompartmental
 
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | M0: No metastasis
OR
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |IB
The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | G1: Low grade
 
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | T2: Extracompartmental
OR
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | M0: No metastasis
 
|-
[Disease name] may be diagnosed at any time if one or more of the following criteria are met:  
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |IIA
* Criteria 1
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | G2: High grade
* Criteria 2
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | T1: Intracompartmental
* Criteria 3
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | M0: No metastasis
 
|-
OR
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |IIB
 
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | G2: High grade
'''IF there are clear, established diagnostic criteria'''
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | T2: Extracompartmental
 
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | M0: No metastasis
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |III
OR
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | G1 or G2
 
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | T1 or T2
The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
| style="padding: 5px 5px; background: #F5F5F5; font-weight: bold; text-align:center;" | M1: Regional or distant metastasis
 
|}
OR
 
The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
 
OR
 
'''IF there are no established diagnostic criteria'''
 
There are no established criteria for the diagnosis of [disease name].


==References==
==References==
Line 130: Line 123:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: Orthopedics]]
[[Category: Oncology]]
[[Category: Up-To-Date]]

Revision as of 04:55, 23 January 2019

Chondrosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chondrosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chondrosarcoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chondrosarcoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chondrosarcoma diagnostic study of choice

CDC on Chondrosarcoma diagnostic study of choice

Chondrosarcoma diagnostic study of choice in the news

Blogs on Chondrosarcoma diagnostic study of choice

Directions to Hospitals Treating Chondrosarcoma

Risk calculators and risk factors for Chondrosarcoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Diagnostic Study of Choice

Study of choice

[Name of the investigation] is the gold standard test for the diagnosis of [disease name].

OR

The following result of [gold standard test] is confirmatory of [disease name]:

  • [Result 1]
  • [Result 2]

OR

[Name of the investigation] must be performed when:

  • The patient presents with [symptom/sign 1], [symptom/sign 2], and [symptom/sign 3].
  • A [name of test] is positive for [sign 1], [sign 2], and [sign 3] in the patient.

OR

[Name of the investigation] is the gold standard test for the diagnosis of [disease name].

OR

The diagnostic study of choice for [disease name] is [name of the investigation].

OR

There is no single diagnostic study of choice for the diagnosis of [disease name].

OR

There is no single diagnostic study of choice for the diagnosis of [disease name], but [disease name] can be diagnosed based on [name of the investigation 1] and [name of the investigation 2].

OR

[Disease name] is primarily diagnosed based on the clinical presentation.

OR

Investigations:

  • Among the patients who present with clinical signs of [disease name], the [investigation name] is the most specific test for the diagnosis.
  • Among the patients who present with clinical signs of [disease name], the [investigation name] is the most sensitive test for diagnosis.
  • Among the patients who present with clinical signs of [disease name], the [investigation name] is the most efficient test for diagnosis.

The comparison of various diagnostic studies for [disease name]

Test Sensitivity Specificity
Test 1 ...% ...%
Test 2 ...% ...%

[Name of test with higher sensitivity and specificity] is the preferred investigation based on the sensitivity and specificity

Diagnostic results

The following finding(s) on performing [investigation name] is(are) confirmatory for [disease name]:

  • [Finding 1]
  • [Finding 2]
Sequence of Diagnostic Studies

The [name of investigation] must be performed when:

  • The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
  • A positive [test] is detected in the patient, to confirm the diagnosis.

OR

The various investigations must be performed in the following order:

  • [Initial investigation]
  • [2nd investigation]

Enneking (MSTS) Staging System

  • The Enneking surgical staging system (also known as the MSTS system) for malignant musculoskeletal tumors based on histological and radiographic characteristics of the tumor host margin.[1][2]
  • It is widely accepted and routinely used staging system.
Stages Grade Site Metastasis
IA G1: Low grade T1: Intracompartmental M0: No metastasis
IB G1: Low grade T2: Extracompartmental M0: No metastasis
IIA G2: High grade T1: Intracompartmental M0: No metastasis
IIB G2: High grade T2: Extracompartmental M0: No metastasis
III G1 or G2 T1 or T2 M1: Regional or distant metastasis

References

  1. ↑ Jawad MU, Scully SP (2010). "In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system". Clin Orthop Relat Res. 468 (7): 2000–2. doi:10.1007/s11999-010-1315-7. PMC 2882012. PMID 20333492.
  2. ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Chondrosarcoma_diagnostic_study_of_choice&oldid=1539425"